Diarrhea Treatment with Lomotil and Alternative Options

Comparative Efficacy and Safety

Diphenoxylate-atropine requires a prescription and is generally less effective than loperamide for acute diarrhea, with more central effects and peripheral side effects compared to loperamide, as recommended by the American Gastroenterological Association 1, 2
Intestinal transit is more prolonged by both diphenoxylate and atropine than by loperamide, with a moderate strength of evidence 1
Monitor for side effects including central nervous system effects, which are more common with diphenoxylate than with newer agents like loperamide, according to the American College of Gastroenterology 2

Loperamide is often preferred over Lomotil for acute diarrhea with an initial dose of 4 mg followed by 2 mg every 2-4 hours or after every unformed stool (maximum 16 mg daily), as suggested by the European Society for Medical Oncology 3, 4
For cancer patients with therapy-associated diarrhea, octreotide at 500 μg three times daily subcutaneously may be considered if loperamide fails, with a low strength of evidence 5